Skip to main content
. 2022 Apr 27;71(7):1426–1439. doi: 10.1136/gutjnl-2021-326784

Figure 2.

Figure 2

Treatment considerations for patients with IBD who develop COVID-19 infection. Adapted from the latest European Crohn’s and Colitis Organisation and American Gastroenterological Association guidelines.76 77 5-ASA, 5-aminosalicylic acid; IBD, inflammatory bowel disease.